Abstract
RESISTING what has been described as unprecedented pressure to retain present schedule of poliomyelitis immunization, which relies entirely on live virus oral poliomyelitis vaccine (OPV), Advisory Committee on Immunization Practices (ACIP) of Centers for Disease Control and Prevention (CDC) has voted to recommend switching to enhanced inactivated poliomyelitis vaccine (IPV) for first 2 doses of childhood polio immunization schedule. The oral vaccine will continue to be recommended for remaining 2 doses of schedule. The decision, arrived at after prolonged deliberations (6 public meetings and 2 previous ACIP votes) marks the most significant change in policy since introduction of oral polio vaccine in 1961, says draft statement on new recommendations for poliovirus immunization that was approved by committee. Its recommendation must be accepted by CDC Director David Satcher, MD. Physicians are free to continue using an all-OPV schedule if they wish.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
